News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
04 01 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading...
-
03 15 2021 Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
-
03 11 2021 - Company to repurchase $900 million of its shares in first half of 2021At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
03 08 2021 Quest to acquire Mercy's outreach laboratory business serving providers and patients in Arkansas, Kansas, Missouri and OklahomaQuest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a...
-
03 02 2021 -Quest will remain the exclusive, national clinical reference laboratory and testing provider for BlueCross BlueShield of Western New York and BlueShield of Northeastern New York members for all products-SECAUCUS, N.J., March 2, 2021— BlueCross BlueShield of Western New York and BlueShield of Northeastern New York, two of New York’s leading insurance carriers, and Quest Diagnostics (NYSE:...